|
Woerner, Margaret G; Correll, Christoph U; Alvir, Jose Ma J et al. (2011) Incidence of tardive dyskinesia with risperidone or olanzapine in the elderly: results from a 2-year, prospective study in antipsychotic-naïve patients. Neuropsychopharmacology 36:1738-46
|
|
Correll, Christoph U; Leucht, Stefan; Kane, John M (2004) Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry 161:414-25
|
|
Kane, J M (1999) Pharmacologic treatment of schizophrenia. Biol Psychiatry 46:1396-408
|
|
Kane, J M (1999) Management strategies for the treatment of schizophrenia. J Clin Psychiatry 60 Suppl 12:13-7
|
|
Kane, J M (1999) Tardive dyskinesia in affective disorders. J Clin Psychiatry 60 Suppl 5:43-7;discussion 48-9
|
|
Miller, C H; Mohr, F; Umbricht, D et al. (1998) The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics. J Clin Psychiatry 59:69-75
|
|
Woerner, M G; Alvir, J M; Saltz, B L et al. (1998) Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Am J Psychiatry 155:1521-8
|
|
Chakos, M H; Alvir, J M; Woerner, M G et al. (1996) Incidence and correlates of tardive dyskinesia in first episode of schizophrenia. Arch Gen Psychiatry 53:313-9
|
|
Umbricht, D; Kane, J M (1996) Medical complications of new antipsychotic drugs. Schizophr Bull 22:475-83
|
|
Woerner, M G; Alvir, J M; Kane, J M et al. (1995) Neuroleptic treatment of elderly patients. Psychopharmacol Bull 31:333-7
|
Showing the most recent 10 out of 26 publications
